IART
Price
$27.49
Change
+$1.02 (+3.85%)
Updated
May 16, 6:59 PM EST
69 days until earnings call
SNN
Price
$25.84
Change
+$0.14 (+0.54%)
Updated
May 16, 6:59 PM EST
70 days until earnings call
Ad is loading...

IART vs SNN

Header iconIART vs SNN Comparison
Open Charts IART vs SNNBanner chart's image
Integra LifeSciences Holdings
Price$27.49
Change+$1.02 (+3.85%)
Volume$541.95K
CapitalizationN/A
Smith & Nephew
Price$25.84
Change+$0.14 (+0.54%)
Volume$370.23K
CapitalizationN/A
View a ticker or compare two or three
IART vs SNN Comparison Chart

Loading...

IARTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SNNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
IART vs. SNN commentary
May 17, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IART is a Hold and SNN is a Buy.

COMPARISON
Comparison
May 17, 2024
Stock price -- (IART: $26.47 vs. SNN: $25.71)
Brand notoriety: IART and SNN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IART: 67% vs. SNN: 89%
Market capitalization -- IART: $2.77B vs. SNN: $10.95B
IART [@Medical Specialties] is valued at $2.77B. SNN’s [@Medical Specialties] market capitalization is $10.95B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.47B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IART’s FA Score shows that 1 FA rating(s) are green whileSNN’s FA Score has 1 green FA rating(s).

  • IART’s FA Score: 1 green, 4 red.
  • SNN’s FA Score: 1 green, 4 red.
According to our system of comparison, SNN is a better buy in the long-term than IART.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IART’s TA Score shows that 5 TA indicator(s) are bullish while SNN’s TA Score has 5 bullish TA indicator(s).

  • IART’s TA Score: 5 bullish, 3 bearish.
  • SNN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IART is a better buy in the short-term than SNN.

Price Growth

IART (@Medical Specialties) experienced а +6.26% price change this week, while SNN (@Medical Specialties) price change was +2.84% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.02%. For the same industry, the average monthly price growth was +4.43%, and the average quarterly price growth was +17.15%.

Reported Earning Dates

IART is expected to report earnings on Jul 24, 2024.

SNN is expected to report earnings on Jul 25, 2024.

Industries' Descriptions

@Medical Specialties (+2.02% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for IART with price predictions.
OPEN
A.I.dvisor published
a Summary for SNN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
SNN($10.9B) has a higher market cap than IART($2.77B). IART (41.30) and SNN (40.76) have similar P/E ratio . SNN YTD gains are higher at: -4.006 vs. IART (-39.219). SNN has higher annual earnings (EBITDA): 956M vs. IART (256M). IART (309M) and SNN (302M) have equal amount of cash in the bank . IART has less debt than SNN: IART (1.68B) vs SNN (3.08B). SNN has higher revenues than IART: SNN (5.55B) vs IART (1.54B).
IARTSNNIART / SNN
Capitalization2.77B10.9B25%
EBITDA256M956M27%
Gain YTD-39.219-4.006979%
P/E Ratio41.3040.76101%
Revenue1.54B5.55B28%
Total Cash309M302M102%
Total Debt1.68B3.08B55%
FUNDAMENTALS RATINGS
IART vs SNN: Fundamental Ratings
IART
SNN
OUTLOOK RATING
1..100
726
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8695
PRICE GROWTH RATING
1..100
8857
P/E GROWTH RATING
1..100
1286
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNN's Valuation (5) in the Medical Specialties industry is significantly better than the same rating for IART (75). This means that SNN’s stock grew significantly faster than IART’s over the last 12 months.

SNN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as IART (100). This means that SNN’s stock grew similarly to IART’s over the last 12 months.

IART's SMR Rating (86) in the Medical Specialties industry is in the same range as SNN (95). This means that IART’s stock grew similarly to SNN’s over the last 12 months.

SNN's Price Growth Rating (57) in the Medical Specialties industry is in the same range as IART (88). This means that SNN’s stock grew similarly to IART’s over the last 12 months.

IART's P/E Growth Rating (12) in the Medical Specialties industry is significantly better than the same rating for SNN (86). This means that IART’s stock grew significantly faster than SNN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IARTSNN
RSI
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
36%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
57%
Momentum
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
53%
MACD
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
54%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
57%
Advances
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 7 days ago
54%
Declines
ODDS (%)
Bearish Trend 21 days ago
72%
Bearish Trend 22 days ago
58%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
48%
Aroon
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
62%
View a ticker or compare two or three
Ad is loading...
IARTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SNNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LICYX15.700.17
+1.09%
Lord Abbett International Equity I
RIRBX69.300.62
+0.90%
American Funds Capital Income Bldr R2
CAAIX40.270.29
+0.73%
Ariel Appreciation Institutional
TEBIX16.560.07
+0.42%
Franklin Mutual Beacon A
TGVNX27.99N/A
N/A
TCW Relative Value Mid Cap N

IART and

Correlation & Price change

A.I.dvisor indicates that over the last year, IART has been loosely correlated with MASI. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IART jumps, then MASI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IART
1D Price
Change %
IART100%
+0.11%
MASI - IART
45%
Loosely correlated
+0.79%
MDT - IART
44%
Loosely correlated
+0.50%
TFX - IART
40%
Loosely correlated
+3.37%
GMED - IART
39%
Loosely correlated
+2.69%
MYGN - IART
39%
Loosely correlated
-2.76%
More

SNN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNN has been loosely correlated with ZBH. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if SNN jumps, then ZBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNN
1D Price
Change %
SNN100%
-0.23%
ZBH - SNN
57%
Loosely correlated
+0.84%
TFX - SNN
52%
Loosely correlated
+3.37%
MDT - SNN
52%
Loosely correlated
+0.50%
ABT - SNN
48%
Loosely correlated
+0.56%
SYK - SNN
48%
Loosely correlated
+2.37%
More